Drug Shortage Report for TEVA-PROGESTERONE
| Report ID | 141480 |
| Drug Identification Number | 02439913 |
| Brand name | TEVA-PROGESTERONE |
| Common or Proper name | PROGESTERONE 100MG CAPS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PROGESTERONE |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | G03DA |
| ATC description | PROGESTOGENS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-06-23 |
| Estimated end date | 2022-04-30 |
| Actual end date | 2022-04-27 |
| Shortage status | Resolved |
| Updated date | 2022-04-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.